©OVERCOME

final programmeDear Colleagues, dear Friends,
Due to the pandemic situation, we had to rethink our organization for EUMS 2020. Since the initial
proposal of a hybrid meeting will not be possible in December, we had 2 possibilities:• 3 days of fully dematerialized meeting• Define a fully different virtual format to make it more attractive and more interaction designed.
Our group is very happy to announce you the EUMS WEEK – November 30th to December 4th – with 6
hot topics virtuals sessions on MCS from 6 p.m. to 8 p.m. Monday to Wednesday, 5 p.m. to 8 p.m. on
Thursday and 4 p.m. to 8 p.m. on Friday..
As usual, interaction will be the corner stone of the session with 2-3 short presentations around 1 topic
followed by an interactive discussion with international KOL.
Industry update will be included in the session when related to the topic and a full update session will
be organized for the others.
Friday we’ll give the chance to our young colleagues to share and discuss debated clinical cases andthe best abstracts will be selected for short interactive discussion.
Finally, industrial symposia will be organized before the sessions. After one year of very few event
dedicated to this field, we hope that this format will help our community to interact and work in the best
condition we can offer in this context.
Of course, Hannover meeting will happen in 2021. Moreover, between EUMS week next December andEUMS 2021, we will organize other regular appointments to keep the relationship ongoing and our field
to progress.
Talk to you soon.
All the best.
The Scientific committee
SCIENTIFIC COMMITTEELOGISTICS ORGANISATION AND PARTNERSHIPA. EL BANAYOSY, Oklahoma City - USA

OVERCOME

P. LEPRINCE, Paris - FRA

13-15, Rue des Sablons 75116 Paris, FRANCE

J. SCHMITTO, Hannover - GER

Ph: +33 (0)1 40 88 97 97 - Fax: +33 (0)1 43 59 76 07

D. ZIMPFER, Vienna - AUT

E-mail: eums@overcome.fr

n MONDAY, NOVEMBER 30, 2020
06:00
08:10 PM CARDIOGENIC SHOCK AND SHORT TERM SUPPORTChairs: P. Leprince, Paris – FRA - J. Schmitto, Hannover – GER
Panelists: J. Bauersachs, Hannover – GER, A. El Banayosy, Oklahoma City – USA,
E. Rame, Philadelphia – USA, M. Slaughter, Louisville – USA
A. Mebazza, Paris – FRAn

Cardiogenic shock: new classification highlighting clinical trialn

BTB with ECMO: French registry

B. Levy, Nancy – FRAØ Discussion – First discussant

J. Bauersachs, Hannover – GER

nImpella in AMIn

Hube and spoke organization and results

Ø Discussion - First discussantnn

C. Napp, Hannover – GER
A. El Banayosy, Oklahoma City – USA
M. Slaughter, Louisville – USA

Hemodynamic deterioration on the cardiac transplant waiting list :risk and benefit of ECMO strategy

G. Coutance, Paris – FRA

Modification on the UNOS cardiac graft allocation system: role of ECMOand its impact on heart transplantation programs and outcome M. Slaughter, Louisville – USA

Ø Discussion - First discussantn

ECMELLA 2.0 single arterial access – concept and results

nUpdate on miniaturized temporary percutaneous LVADn

ECMO updateØ Discussion - First discussant

E. Rame, Philadelphia – USA
E. Potapov, Berlin – GER
E. Rame, Philadelphia – USA
M. Strüber, Newark – USA
A. El Banayosy, Oklahoma City – USA

n TUESDAY, DECEMBER 1, 2020
EXPLORING NEW HORIZONS!
05:15
05:45 PM Workshop with the support of Berlin HeartIn this workshop we show possibilities in the context of therapy with terminal heart failure inadults by presenting current data and case studies. Which new paths can be taken with themobile driving system? First experiences and prospects. B. H. Schnitzer, F. Gräbner, Berlin - GER
06:00
07:20 PM TAH AND BIVAD

Chairs: A. El Banayosy, Oklahoma City – USA, D. Zimpfer,Vienna – AUT
Panelists: F. Arabia, Los Angeles – USA, G. Gerosa, Padua – IT, G. Laufer, Vienna – AUT, J. Lavee,Tel Aviv – IL, S. Marasco, Melbourne – AUS, I. Netuka, Prague – CZE
I. Knesevicz, Ljubliana – SLO

nIs there still a need for TAH/BIVAD?

nOutcome of Syncardia TAH implantation in ECMO patients

P-E. Noly, Montréal – CAN

nCarmat: Initial international experience

Y. Pia, Nur-Sultan – KZKØ DiscussionnnDebate:¨

BI-Levitronix is my BIVAD of choice

A. Tatooles, Oak Lawn – USA¨Pulsatile VADs are my BIVAD of choice

A. Ruhparwar Essen – GER

Challenges and technical limitations using CF pumps as BIVAD/TAH J. Schmitto, Hannover – GER

Ø Discussion
07:20
08:10 PM n Update on new TAH¨

SYNCARDIA

M. Slepian, Tucson – USA¨

REALHEART - An intelligent TAH

A. Najar, Västerås – SWE¨

BIVACOR Design Features of the BiVACOR Rotary Total Artificial Heart N. Greatrex, Cerritos – USA¨

REINHEART - First experimental results of a novel TAH¨

G. Dogan, Hannover – GER

SMARTHEART - Continuous-Flow Total Artificial Heart: Cleveland Clinic Technology Update
J. Karimov, Cleveland – USAn WEDNESDAY, DECEMBER 2, 2020
06:00
07:15 PM MCS AND INFECTION

Chairs: A. El Banayosy, Oklahoma City – USA, J. Schmitto, Hannover – GER
Panelists: S. Aslam, San Diego – USA, C. Fegbeutel, Hannover – GER, J. Hanke, Hannover – GER
R. Hooker, Oklahoma City – USA, J. Kobashigawa, Los Angeles – USA, P. Leprince, Paris – FRA,
J. Long, Oklahoma City – USA, F. Ramjankhan, Den Dolder – NLD, D. Zimpfer, Vienna – AUTnClinical scenarion

MCS Infections: Epidemiology and ManagamentR. Hooker, Oklahoma City – USA
S. Aslam, San Diego – USA

Ø Discussion
nManagement of infected driveline: prevention and treatmentnOverview on Surgical management.

nTransplanting MCS infected patients: outcome

J. Hanke, Hannover – GER
D. Zimpfer, Vienna – AUT

J. Kobashigawa, Los Angeles – USA

Ø Discussion

07:15
08:10 PM NEW TECHNOLOGIES 1

J. Long, Oklahoma City – USA

nPriorities requirement for new devices: clinician point of viewnABBOTT - Keeping the Momentum going: Observations with the HeartMate 3 from the Intermacs Registry

R. L. Kormos – USA
G. Davis – USAn

MEDTRONIC - Industry updaten

EVAHEART: DCT inflow technology, clinical advantages, outcomes and future outlook

T. Motomura, Houston – USA

n THURSDAY, DECEMBER 3, 2020
MCS STRATEGIES IN 2020 – STATUS QUO
05:00
06:00 PM Symposium with the support of Abiomed
Chair: J. Schmitto, Hannover – GERnECpella – When & how?

A. Bernhardt, Hamburg – GERn

Bridge to new strategies

P. Akhyari, Düsseldorf – GERn

ECpella in special indications

J. Belohlávek, Prague – CZE
ˆ

06:05
06:35 PM LVAD IN LESS SICK PATIENTS: ARE WE READY FOR ROADMAP 2?

Chairs: G. Laufer, Vienna – AUT, J. Long, Oklahoma – USA
Panel discussion (rood map investigators): Y. Barac Tel Aviv – ISR, G. Baudry, Lyon – FRA,
M. Crespo, La Coruna – ESP, D. Horstmanshof, Oklahoma City – USA, G. Lebreton, Paris – FRA,
P. Mohacsi, Zurich-Basel – SUI, E. Potapov, Berlin – GER, R. Starling, Cleveland – USA,
N. Uriel, New York – USA

06:35
08:20 PM NEW TECHNOLOGIES 2nnnnnnnn

Engineering point of view on requirements for new devices?

M. Granegger, Vienna – AUT

ABBOTT - Opportunities for enhancing outcomes with HeartMate 3 in small patients
M. Muller – NLD
BERLIN HEART - BERLIN HEART EXCOR® ACTIVE – First impressions of the new driving unit
M. Meißner, Berlin – GER
CORWAVE: Update on CorWave LVAD, the pulsatile wave membrane pump T. Snyder, Paris – FRACARDIOTWIST: Implantable cardiac assist device using twisting
extra ventricular compression
CH Biomedical - CH-VAD® Clinical Trial Experience in China

M. Dahliri, Teheran – IRT. Zhou, Oxford – UK

ReinVAD - The ReinVAD LVAD: Smart Technology to Enhance Long-Term Circulatory Support Therapy
R. Graefe, Aachen – GER
Mi-VAD - The Next Generation of Ventricular Assist Devices in the Treatment of Advanced Heart Failure
S. Kushwaha, Rochester – USAn

Novel concept of a Rotary Assited Pulsatile-Pump - The RAP-Pumpn

CORASSIST - Relaxing the diastolic heart

F.-Horn, Tatingen – GER
Y. Feld, Haifa - IL

n FRIDAY, DECEMBER 4, 2020
08:00 AM HANDS-ON-WORKSHOP TO LEARN IMPLANTATION TECHNIQUES OF MECHANICAL
12:00 PM CIRCULATORY SUPPORT DEVICES

Workshop: G. Dogan, J. Hanke, S. Mariani, J. Schmitto Hannover surgical MCS-TeamSIMDAX - A MUST-HAVE IN CRITICAL SETTINGS?
04:00
05:00 PM Symposium with the support of Orion Pharma
Chair: J. Gummert, Bad Oeynhausen – GER
n…in terms of ECLS weaning
n…in terms of LVAD implantationn…in terms of heart transplantation

C. Hagl, Munich – GER
J. Schmitto, Hannover – GER
U. Boeken, Dusseldorf – GER

05:05
06:35 PM MCS AND COVID-19

Chairs: A. Haverich, Hannover – GER, P. Leprince, Paris – FRA
Panelists: A. Combes, Paris – FRA, G. Gorochov, Paris-FRA G. Lebreton, Paris – FRA,J. Long, Oklahoma City – USA, R. Lorusso, Maastricht – NLD, E. Rame, Philadelphia – USA,
R. Tarazi, Hadiya – KWT, A. Vincentelli, Lille – FRA
n COVID and the Heart
A. Haverich, Hannover – GERn Hub and spoke organization in Ile de France during the COVID-19 pandemic G. Lebreton, Paris – FRAn Cardiac retransplantation in a COVID-ilness patient?
A. Vincentelli, Lille – FRAØ Discussion
n VA ECMO in COVID pandemic
R. Lorusso, Maastricht – NLD
n COVID Myocarditis: is it real?
E. Rame, Philadelphia – USA
n COVID, ECMO and Cytosorbents
G. Gorochov, Paris – FRAØ Discussion
06:40
08:00 PM OUTCOME AND HIGHLIGHTS IN MCS

Chairs: A. Elbanayosy, Oklahoma – USA, P. Leprince, Paris – FRA, J. Schmitto, Hannover – GER,
D. Zimpfer, Vienna – AUTn Best abstract Awards
n Abstract 1: Videoscopic assistance in VAD implantation - a strategy to minimise complications
W. Koen, Cape Town – RSAØ Discussionn Abstract 2: Dynamic echo-guided left ventricular assist device pump speed optimization forexercise maximization
M. Stapor, Krakow – POL
Ø Discussionn VAD outcome throughout the world
B. Meyns, Leuven – BEL
Ø Discussionn Tips and tricks to improve a better long term support outcome
S. Mariani, Hannover – GER
Ø Discussionn MCS highlights in 2020
D. Zimpfer, Vienna – AUT
Ø Discussion

n THANKS TO OUR MAJOR SPONSORSn THANKS TO OUR SPONSORS©OVERCOME

n GENERAL INFORMATIONORGANISATION & PARTNERSHIPS
Patricia Lhote
Overcome13-15, rue des Sablons - 75116 PARIS
Ph.: +33 (0)1 40 88 97 97
Fax: +33 (0)1 43 59 76 07
eums@overcome.fr

GENERAL INFORMATIONS
If you need information about your visit to the e-EUMS, we invite you to visit the General Information room
visible from the e-congress reception desk. The whole team remains connected to accompany you in thisnew experience.
Opening of the welcome desk
Monday November 30 from 17.30 to 20.15
Tuesday December 1 from 16.45 to 20.15
Wednesday December 2 from 17.30 to 20.10
Thursday December 3 from 16.30 to 20.20
Friday December 4 from 15.30 to 20.00

CERTIFICATE OF ATTENDANCE
Certificate of attendance will be sent by email the week following the congress.

EXHIBITION
We invite you to visit the exhibition hall, you will be able to meet the congress partner’s.
eums@overcome.fr